Webcast: Women’s Health and the Role of the Pharmacist
November 3rd 2021Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.
Expert: Build Back Better Bill Would Give Federal Government Involvement on Drug Prices
November 2nd 2021Lindsay Bealor Greenleaf, MBA, JD, Vice President of ADVI Health, discusses a new poll from the Kaiser Family Foundation that found that 83% of Americans believe the government should be allowed to negotiate lower drug prices, for both those on Medicare and in private insurance plans.
Expert: How Parents Feel About Vaccinating Their 5 to 11 Year Old Children Against COVID-19
November 1st 2021Linda Mendonça, DNP, RN, PHNA-BC, president of the National Association of School Nurses, discusses a new poll released by the COVID-19 Vaccine Education and Equity Project and the National Association of School Nurses about parents’ plans to vaccinate their school-aged children.
Expert: Safety, Efficacy of Psilocybin May Be Negatively Impacted With Microdosing
October 29th 2021Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, on his recent presentations at Insight 2021 and the virtual Sana Symposium on psychedelic adverse effects and drug-drug interactions.
Expert: How Social Media Impacts the Mental Health of Health Care Professionals
October 27th 2021Paula Durlofsky, PhD, a writer for the American Psychological Association's Device Management and Digital Intelligence committee discusses how social media has impacted the mental health of health care professionals in recent years, including the COVID-19 Pandemic.
Overview of Burkitt Lymphoma, the Patient Populations Most Impacted
October 25th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
This World Standards Week, USP Sheds Light on Key Shifts in Standards Development
October 25th 2021World Standards Week is October 25 to 29, so Pharmacy Times interviewed Jaap Venema, PhD, EVP and CSO at USP, on some of the key shifts that have occurred in USP’s standards development during the COVID-19 pandemic.
Current Treatments, Drug Pipeline, Initial Management in Oncologic Emergencies
October 21st 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains the initial management process for oncologic emergencies, the treatments currently available, and treatments coming in the drug pipeline.
How the National Blood Shortage May Impact Patient Care, Outcomes
October 21st 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses how a national blood shortage could affect patient care and outcomes.
Potential Drug-Drug Interactions With Psilocybin, MDMA, Ketamine
October 21st 2021Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses potential drug-drug interactions with psilocybin, MDMA, and ketamine to consider outside of interactions with psychiatric medications.
Stand Up To Cancer, Jazz Pharmaceuticals Collaborate to Accelerate Drug Development
October 20th 2021In an interview with Pharmacy Times®, Lee Helman, MD, vice chair on Stand Up To Cancer's Scientific Advisory Committee, discusses the research collaboration between Stand Up To Cancer and Jazz Pharmaceuticals.